Start-Up Previews (3/04)
Executive Summary
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups: Biocoatings, Medical Device Start-Ups in Germany, and Orphan Receptor Drug Discovery. Plus these Start-Ups across Health Care: Alteris Therapeutics Inc., Hepaticus Inc., Semafore Pharmaceuticals Inc. and Synta Pharmaceuticals Corp.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.